A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Chinese Subjects with Type 2 Diabetes Mellitus and Poor Blood Glucose Control by Diet and Exercise
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs GZR 18 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Gan&Lee Pharmaceuticals
- 21 Jan 2025 New trial record